Pluchino lab - Regenerative Neuroimmunology
@Pluchinolab
Developing experimental molecular medicines for chronic inflammatory diseases of the brain. 🇬🇧🇺🇸🇮🇹🇫🇷🇿🇦🇭🇰🇺🇦 🦋 Bluesky @pluchinolab.bsky.social
🚀 Excited to see @BristenaIonescu PhD project, with co-first author @Telencephale, featured on the cover of @CellStemCell - Cholesterol-fuelled neurotoxic senescent PMS iNSCs and its pharmacological rescue is a major leap forward! 🎉 (link cell.com/cell-stem-cell…)

First copies of my book are here!! As a new faculty member, I realized that in addition to my research job, I also had a leadership job…and I wasn’t prepared for that. This book is the guide I wish I’d had then, with the goal of helping others now. jenheemstra.com/book
SPIDR enables multiplexed mapping of RNA-protein interactions and uncovers a mechanism for selective translational suppression upon cell stress cell.com/cell/fulltext/…
🗓️Deadline NEXT FRIDAY (1st Aug) for the Poster Abstract Submission for the 8th Cam Neuro Symposium 🧠All neuroscience themes welcome! 🏅Don't miss out - generous prizes available! 📊Register and submit your abstract: bit.ly/46QQ1WG More info: neuroscience.cam.ac.uk/camneuro-event…
bioRxiv has a dedicated section for negative results. Use it. Share negative results. Your colleagues will appreciate it.
Profiling Epigenetic Aging at Cell‐Type Resolution Through Long‐Read Sequencing - Eames - Aging Cell - Wiley Online Library onlinelibrary.wiley.com/doi/full/10.11…
How stem cells respond to infection, inflammation and ageing | Nature Reviews Immunology nature.com/articles/s4157…
Mast cells regulate the brain-dura interface and CSF dynamics cell.com/cell/fulltext/…
Lord Chris Smith has been elected as the new Chancellor of the University of Cambridge. Lord Smith said “To be elected as Chancellor of the University I love is a huge honour. I’m thrilled." Read more about Lord Smith and the Chancellor election 👉 cam.ac.uk/news/new-chanc…
Great seminar by Anna Kajaste-Rudnitski on innate anti-viral immunity, inflammation & next-gen gene therapies! Implications for understanding cell function in new treatments for degenerative conditions like #progressiveMS

#StemCell Therapy for #MS🎧New MS Living Well Podcast! Guests: @Pluchinolab @MSDoc_Freedman bit.ly/46gFi7U🍏apple.co/3IGjKaW @Dr_LPJ @RESTORE_MS @DocforMS @DrJNicholas #neurotwitter Sponsor: @TGTherapeutics
A blood-based epigenetic clock for intrinsic capacity (IC) predicts mortality and is associated with clinical, immunological and lifestyle factors | ... and declines with age nature.com/articles/s4358…
Top-down and bottom-up neuroscience: overcoming the clash of research cultures nature.com/articles/s4158…
REGISTER NOW for our 8th Cam Neuro Symposium: Interventions and Recovery on 10-11th Sep 2025🧠 Join us as a delegate or become one of our sponsors🌟 Find out more here: bit.ly/46QQ1WG or contact us at [email protected] 📩
Interested in showcasing your product and vision to experts and leaders of tomorrow at an international symposium? Exciting Sponsorship Packages available to support our 8th Cambridge Neuroscience Symposium: Interventions and Recovery🧠 Find out more: neuroscience.cam.ac.uk/camneuro-event…
Epigenome profiling identifies H3K27me3 regulation of extracellular matrix composition in human corticogenesis cell.com/neuron/fulltex…
Advancing multiple sclerosis management in older adults nature.com/articles/s4158…
Spatial proteomics of Alzheimer’s disease-specific human microglial states nature.com/articles/s4159…
I think I have shared this already but this is indeed a fantastic piece of extremely elegant cell biology with profound potential implications in development, physiology and disease science.org/doi/10.1126/sc…
We're hiring! Nature Neuroscience is hiring an Associate or Senior Editor with experience in cellular and molecular neuroscience, glia, and genomics to work in our New York or Shanghai office. Applications are due August 19. springernature.wd3.myworkdayjobs.com/en-US/Springer…
Fenebrutinib significantly reduced new lesions with active inflammation in people with relapsing MS in a Phase 2 trial. buff.ly/Hi8q6SO #MultipleSclerosis #MSTreatment #MSResearch #MSNews